immunity · Mechanism Report
Basophils release histamine and eosinophils participate in allergic Th2 immune responses
Basophils release histamine, and eosinophils are key participants in allergic Th2 immune responses.
This is what AI claimed
Basophils release histamine and eosinophils participate in allergic Th2 immune responses.
Executive summary
The claim describes basophils as histamine-releasing cells and eosinophils as active contributors to allergic type 2 immunity. The mechanism framing shows histamine degranulation and Th2-driven eosinophil recruitment, activation, and feedback that sustain allergic inflammation.
Verified conclusion
Allergic diseases involve highly coordinated cellular cascades. In allergic type 2 (Th2) immune responses, basophils and eosinophils function as key cellular players, driving both immediate hypersensitivity and ongoing inflammatory pathways.
Cellular mechanisms of histamine release
- Degranulation dynamics: Basophils store histamine in specialized secretory granules. When an individual basophil is activated, it undergoes classical anaphylactic degranulation, releasing approximately 100% of its stored histamine. In bulk laboratory assays, total histamine release ranges from 10% to 90%, representing the proportion of the cellular population successfully stimulated.
- Intracellular signaling: This process is initiated when allergens crosslink IgE antibodies bound to high-affinity Fc$\epsilon$RI receptors. This triggers Src-family kinases (such as Lyn) to phosphorylate ITAMs, recruiting Spleen Tyrosine Kinase (Syk). Downstream, phospholipase C$\gamma$ (PLC$\gamma$) activation generates inositol 1,4,5-trisphosphate ($\text{IP}_3$), mobilizing calcium ($\text{Ca}^{2+}$) to drive the exocytosis of histamine-rich granules.
Eosinophil dynamics in Th2 polarization
- Recruitment and activation: During Th2 immune responses, Th2 cells and group 2 innate lymphoid cells (ILC2s) secrete IL-5, the dominant cytokine controlling eosinophil maturation, survival, and recruitment. Concurrently, IL-4 and IL-13 stimulate the release of eotaxins (CCL11, CCL24, CCL26) and the expression of VCAM-1, drawing eosinophils into inflamed tissues.
- Regulatory and effector roles: Beyond causing tissue damage through cationic proteins, eosinophils act as non-professional antigen-presenting cells (APCs) via MHC class II expression. By releasing preformed cytokines (IL-4, IL-13, and IL-25), they establish a positive feedback loop that maintains the type 2 immune state and prevents a shift toward neutrophil-rich Th1/Th17 pathways.
Bottom line
- The claim is fully supported by scientific evidence. Basophils release histamine via precise, $\text{Ca}^{2+}$-dependent degranulation pathways, and eosinophils serve as both tissue-damaging effectors and critical upstream orchestrators that maintain Th2 immune polarization.
References
- A linear correlation between histamine release and degranulation of ... — pmc.ncbi.nlm.nih.gov
- Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery - PubMed — pubmed.ncbi.nlm.nih.gov
- Antibody mediated regulation of basophils - PMC - NIH — pmc.ncbi.nlm.nih.gov
- Activation of Human Peripheral Basophils in Response to High IgE Antibody Concentrations without Antigens — pmc.ncbi.nlm.nih.gov
- Eosinophils and Th2 immunity: contemporary insights - PMC — pmc.ncbi.nlm.nih.gov
- Interleukin-5 in the Pathophysiology of Severe Asthma - PMC — pmc.ncbi.nlm.nih.gov
- Eosinophil Cytokines, Chemokines, and Growth Factors — frontiersin.org
- Eotaxin and the attraction of eosinophils to the asthmatic lung — ncbi.nlm.nih.gov
- Interleukin-13 in Asthma and Other Eosinophilic Disorders — frontiersin.org
- Eosinophils and allergic airway disease: there is more to the story. — pmc.ncbi.nlm.nih.gov
- A Player and Coordinator: The Versatile Roles of Eosinophils in ... — pmc.ncbi.nlm.nih.gov
- Re-defining the unique roles for eosinophils in allergic respiratory inflammation - PubMed — pubmed.ncbi.nlm.nih.gov
- Type 2 immunity in allergic diseases | Cellular & Molecular ... — nature.com
- T Helper 2 Cell Overview | Thermo Fisher Scientific - JP — thermofisher.com
- Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience — pmc.ncbi.nlm.nih.gov
- IL-5- and eosinophil-mediated inflammation: from discovery to therapy — academic.oup.com
- Frontiers | Interleukin-5 in the Pathophysiology of Severe Asthma — frontiersin.org
- The Possible Roles of IL-4/IL-13 in the Development of Eosinophil ... - PMC — pmc.ncbi.nlm.nih.gov
- Role of IL-5 in eosinophil-associated diseases and prospects for ... — frontiersin.org
See a full patient report verified like this
Book a walkthrough